Kolonin Mikhail G, Saha Pradip K, Chan Lawrence, Pasqualini Renata, Arap Wadih
The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Nat Med. 2004 Jun;10(6):625-32. doi: 10.1038/nm1048. Epub 2004 May 9.
Obesity is an increasingly prevalent human condition in developed societies. Despite major progress in the understanding of the molecular mechanisms leading to obesity, no safe and effective treatment has yet been found. Here, we report an antiobesity therapy based on targeted induction of apoptosis in the vasculature of adipose tissue. We used in vivo phage display to isolate a peptide motif (sequence CKGGRAKDC) that homes to white fat vasculature. We show that the CKGGRAKDC peptide associates with prohibitin, a multifunctional membrane protein, and establish prohibitin as a vascular marker of adipose tissue. Targeting a proapoptotic peptide to prohibitin in the adipose vasculature caused ablation of white fat. Resorption of established white adipose tissue and normalization of metabolism resulted in rapid obesity reversal without detectable adverse effects. Because prohibitin is also expressed in blood vessels of human white fat, this work may lead to the development of targeted drugs for treatment of obese patients.
肥胖在发达社会中是一种日益普遍的人类疾病。尽管在理解导致肥胖的分子机制方面取得了重大进展,但尚未找到安全有效的治疗方法。在此,我们报告一种基于在脂肪组织血管中靶向诱导细胞凋亡的抗肥胖疗法。我们利用体内噬菌体展示技术分离出一种归巢于白色脂肪血管的肽基序(序列为CKGGRAKDC)。我们发现CKGGRAKDC肽与一种多功能膜蛋白抗增殖蛋白结合,并确定抗增殖蛋白为脂肪组织的血管标志物。将促凋亡肽靶向脂肪血管中的抗增殖蛋白会导致白色脂肪消融。已形成的白色脂肪组织的吸收和代谢的正常化导致肥胖迅速逆转,且未检测到不良反应。由于抗增殖蛋白也在人类白色脂肪的血管中表达,这项工作可能会促成用于治疗肥胖患者的靶向药物的开发。